Fashion Arena Prague Outlet Collaborates with VFS Global to Promote Czechia's Shopping Appeal in the Gulf & Middle East
This partnership is designed to enhance awareness of Fashion Arena Prague Outlet as a preferred European shopping destination among GCC travelers. Offering over 200 international and Czech fashion brands with year-round discounts of 30%–70%, the outlet is conveniently located just 20 minutes from Prague's city centre. It operates seven days a week and provides a seamless shopping experience across fashion, sportswear, accessories, cosmetics, and home décor.
Through this collaboration, Fashion Arena Prague Outlet and VFS Global will work together on a coordinated promotional strategy that engages both travel trade professionals and consumers. The joint efforts will include outreach to travel agents and tour operators across key Gulf cities through roadshows, trade workshops, and shared marketing initiatives. Travel partners will be supported with tailored incentives, VIP group access, and co-branded promotional opportunities.
Consumer-facing activities will focus on influencer-led campaigns, seasonal promotions, and curated shopping experiences that resonate with GCC travelers. These will be complemented by value-added services such as extra discounts, dining vouchers, and VAT refund assistance to enrich the overall visitor experience.
This collaboration reflects a shared commitment to connecting GCC travelers with premium shopping experiences in Europe and to strengthening Czechia's positioning as a fashion and lifestyle destination.
Quotes from the Partners-
Petr Vejvoda Křivonožka, Senior Tourism & Partnerships Manager, Fashion Arena Prague Outlet, shared:
'We look forward to working closely with VFS Global to welcome more guests from the Gulf and Middle East. Their regional expertise and strong industry relationships will be instrumental in showcasing the outlet's unique appeal.'
GB Srithar, Head – Tourism Services, VFS Global stated:
'We are delighted to support Fashion Arena Prague Outlet in its outreach initiatives to travellers from the GCC region. This collaboration reflects our shared commitment to promoting premium shopping experiences in Czechia through meaningful engagement with the travel trade.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
See - Sada Elbalad
2 hours ago
- See - Sada Elbalad
Trump Threatens UK Drugmakers With 60-Day Deadline to Cut US Prices, 'We'll Use Every Tool We Have'
Taarek Refaat President Donald Trump has issued a stark ultimatum to British pharmaceutical giants, warning they have 60 days to slash the prices of their medicines in the U.S. market or face aggressive action from his administration. 'We will use every tool in our arsenal,' Trump vowed on Saturday, targeting 17 drug companies in an escalating campaign to force them to match the reduced prices they offer in developing nations for the U.S. healthcare system. The move comes as the administration rolls out a wave of new tariffs on dozens of countries, including punitive duties on neighboring Canada, intensifying an already heated global trade climate. British drugmakers AstraZeneca and GSK saw their shares tumble amid investor fears over White House pressure, as Trump seeks to deliver on his pledge to bring down prescription costs for Americans. Analysts warn the policy could have ripple effects across the UK's National Health Service (NHS), which benefits from strong bargaining power with suppliers due to its massive purchasing scale, an advantage that could erode if companies are forced to harmonize prices globally. Trump is pushing for drugmakers to apply a 'most-favored nation' pricing model to Medicaid, the program serving low-income Americans, effectively demanding that the U.S. pay no more than the lowest price offered internationally. 'Cooperation toward global price parity in medicines would be the most effective path for companies, governments, and American patients alike,' Trump said in a statement. But his letter to pharmaceutical executives carried a blunt warning, 'If you refuse, we will use every tool in our arsenal to protect American families from unfair and excessive pricing practices. Americans need lower drug prices today, not tomorrow.' The president's remarks rattled markets, wiping an estimated £16 billion off the European pharmaceutical sector's market value amid concerns that lower U.S. prices could be offset by higher costs elsewhere in the world. Skeptics question whether Trump has the legal authority to impose direct drug price cuts, noting a similar effort during his first term was struck down in court. Back then, Trump accused current pricing models of 'subsidizing socialism abroad' by selling identical medicines, made in the same factories, at cheaper rates overseas, fueling inflated prices at home. Saturday's warning coincided with Trump signing an executive order imposing new tariffs on 68 countries plus the European Union. Canada was hit particularly hard, with duties raised from 25% to 35%, over what the White House called Ottawa's 'failure to cooperate' in halting the flow of illicit drugs, especially fentanyl, into the U.S. Canadian Prime Minister Mark Carney defended his country's efforts, citing 'historic investments in border security to apprehend drug traffickers and end migrant smuggling.' Switzerland, stunned by tariffs of 39%, far higher than anticipated, said it would continue negotiations with Washington to defuse the trade escalation. read more CBE: Deposits in Local Currency Hit EGP 5.25 Trillion Morocco Plans to Spend $1 Billion to Mitigate Drought Effect Gov't Approves Final Version of State Ownership Policy Document Egypt's Economy Expected to Grow 5% by the end of 2022/23- Minister Qatar Agrees to Supply Germany with LNG for 15 Years Business Oil Prices Descend amid Anticipation of Additional US Strategic Petroleum Reserves Business Suez Canal Records $704 Million, Historically Highest Monthly Revenue Business Egypt's Stock Exchange Earns EGP 4.9 Billion on Tuesday Business Wheat delivery season commences on April 15 News Israeli-Linked Hadassah Clinic in Moscow Treats Wounded Iranian IRGC Fighters Arts & Culture "Jurassic World Rebirth" Gets Streaming Date News China Launches Largest Ever Aircraft Carrier News Ayat Khaddoura's Final Video Captures Bombardment of Beit Lahia Business Egyptian Pound Undervalued by 30%, Says Goldman Sachs Videos & Features Tragedy Overshadows MC Alger Championship Celebration: One Fan Dead, 11 Injured After Stadium Fall Lifestyle Get to Know 2025 Eid Al Adha Prayer Times in Egypt Arts & Culture South Korean Actress Kang Seo-ha Dies at 31 after Cancer Battle Arts & Culture Lebanese Media: Fayrouz Collapses after Death of Ziad Rahbani Sports Get to Know 2025 WWE Evolution Results
Daily News Egypt
4 hours ago
- Daily News Egypt
India to continue buying Russian oil despite Trump's sanction threat, officials say
India will continue to purchase cheap Russian oil despite threats of sanctions from U.S. President Donald Trump, Indian officials said on Saturday, in the latest development in a matter New Delhi believed had been settled, according to The New York Times. President Trump said last week that he would penalise India if it did not stop buying Russian oil, without specifying the nature of the potential punishment. On Friday, he pointed to reports that Russian shipments to India had decreased, telling reporters: 'I understand that India is no longer buying oil from Russia… that's what I heard. I don't know if that's correct, but it's a good step. We'll see what happens.' Reuters reported earlier that India's state-run refiners had halted purchases of Russian oil a week ago as discounts shrank in July. On 14 July, Trump threatened to impose 100% tariffs on countries buying Russian oil unless Moscow reached a major peace agreement with Ukraine. The New York Times quoted two senior Indian government officials as saying that 'there has been no change in oil policy'. One of the officials clarified that the government 'has not issued any directives to oil companies to stop or reduce their imports from Russia'. During a press conference a day earlier, India's Ministry of External Affairs spokesperson, Randhir Jaiswal, declined to comment directly on Trump's threat but hinted that the country would stick to its position on Moscow. 'Our bilateral relations with various countries stand on their own footing and should not be viewed from the perspective of a third country,' Jaiswal said. 'India and Russia have a stable and time-tested partnership.' Since the war in Ukraine began, India has significantly increased its imports of Russian oil. Russia is now India's top supplier, providing about 35% of its total supplies, up from less than 1% before the conflict. New Delhi imports more than two million barrels of crude oil per day from Russia, making it the second-largest buyer of Russian oil after China. Officials and analysts suggest that Trump's focus on the issue may be a 'negotiating chip' in the context of ongoing talks between India and the United States to reach a bilateral trade agreement, which is in its early stages. It is noted that China and Turkey, also major importers of Russian oil, have not faced similar threats from Washington. India came under significant pressure during the initial months of the war in Ukraine to scale back its economic ties with Moscow, and this pressure continued as its oil imports grew. However, as the war entered its second year, the international stance on India's oil imports began to shift. New Delhi appeared to have successfully convinced its American and European allies that its large-scale purchases of cheap Russian oil, under a price cap imposed by the G7 and the European Union, were in fact helping to maintain global energy price stability. Early last year, senior U.S. Treasury officials visiting New Delhi stated that India was implementing a mechanism that had proven effective: keeping Russian oil flowing to global markets but at lower prices that reduced Moscow's revenues. Eric Garcetti, who was then the U.S. Ambassador to India, said: 'They bought Russian oil because we wanted someone to buy it at a specific price cap. It wasn't a breach; it was part of the policy design because we were afraid of oil prices going up, and they did their required part.'
Mid East Info
a day ago
- Mid East Info
Eurozone CPI holds steady, reinforcing ECB's wait-and-see approach - Middle East Business News and Information
By Daniela Sabin Hathorn, senior market analyst at The preliminary July reading of Eurozone inflation showed no change in both headline and core CPI, which remained at 2.0% and 2.3% year-over-year, respectively. Markets had been expecting a slight dip in headline inflation to 1.9%, but month-on-month figures suggest price pressures continue to ease, hinting at softer inflation prints ahead if the trend persists. Policy implications: ECB can afford to stay put: The European Central Bank (ECB) appears to be achieving a delicate balance between supporting growth and containing inflation. With the headline CPI exactly at the ECB's 2% target, policymakers are likely comfortable with current conditions. While the risk of undershooting inflation targets cannot be dismissed entirely, the ECB's easing cycle seems to have reached a pause, with no further rate cuts expected through at least the end of 2026. At this point, only a severe and unexpected shock to growth would likely prompt the ECB to cut further, and with most of the tariff uncertainty between the US and the EU now resolved, it is unlikely that such thing will happen anytime soon. For now, the ECB is likely to remain data-dependant, especially as it monitors how the new tariff levels impact growth in different European economies. Market reaction: As for markets, the CPI released hasn't done much to change the sluggish sentiment in European assets. Equity indices are facing increased selling pressure on Friday morning as global sentiment sours on the day that Trump's tariff extension deadline comes to an end, with several countries facing higher tariffs in the absence of a deal. Whilst this isn't the case for the EU, the bullish momentum that was powering equities over the past few weeks seems to have dried up somewhat, leading to a reversal in global equities. Meanwhile, EUR/USD is attempting to find some footing after facing heavy losses this week, primarily on the back of a continued resurgence in the US dollar. Whilst other USD pairs are facing further bearish pressure on Friday, EUR/USD is holding on to the 1.14 mark for the third consecutive session, potentially finding some strength in the CPI data release. However, with the RSI nearing oversold levels and continued upside expected in the dollar, the support is unlikely to hold much longer, with the 100-day SMA at 1.1360 likely to be the next test. EUR/USD daily chart: Past performance is not a reliable indicator of future results.
